Nanoparticles News and Research

RSS

Dysregulation of immune regulator NF-κB drives major human diseases

NF‑κB controls genes involved in inflammation, immunity, cell survival, and proliferation. Triggered by cytokines (TNF‑α, IL‑1β), microbial products, or cellular stress, it translocates to the nucleus and induces pro‑inflammatory mediators.

13 Jul 2026

New bionic skin wound dressing accelerates infected tissue healing

Dressings face a critical limitation: no single product has successfully integrated protective function, wearing comfort, and efficient antibacterial activity.

11 Jul 2026

New method improves understanding of drug delivery nanoparticles

Modern medicine increasingly relies on targeted drug delivery - a process during which tiny particles (nanoparticles) transport drugs to specific parts of the body.

9 Jul 2026

Antifungal nanoparticles made from immune cell membranes fight infections

Tiny particles made from the membranes of human immune cells could offer a promising new way to fight fungal infections that are becoming harder to treat. Engineers at the University of California San Diego created antifungal nanoparticles that target Candida albicans, a fungus responsible for oral and vaginal yeast infections as well as life-threatening bloodstream infections.

9 Jul 2026

Using manganese ferrite nanoparticles to better harness heat against cancer

Scientists have long known that heat can be used to help fight cancer. But heating up tumors and cancer cells is trickier than it sounds.

7 Jul 2026

Study offers practical guidance for future mRNA vaccine patch design

New research could help make future mRNA vaccines easier to store and distribute.

7 Jul 2026

Alexandre Detappe wins ERC grant for nanomedicine-based cancer immunotherapy

The ERC (European Research Council) Proof of Concept grant awarded to Alexandre Detappe (Gustave Roussy/Institut Strauss/Université Paris-Saclay/Inserm) will fund the Nano-BITE project, which aims to improve the ability of the immune system to fight solid tumors through nanomedicine.

1 Jul 2026

Cancer's biggest treatment challenge may be getting solved 250 miles above Earth

For more than two decades, precision oncology has been promoted as the future of cancer treatment, matching therapies to the unique biology of a patient's tumor.

1 Jul 2026

AI-guided microneedle patch changes shape to heal chronic wounds

Chronic wounds remain a major healthcare challenge, especially for people with diabetes, who often experience delayed healing, persistent inflammation, and a higher risk of infection.

26 Jun 2026

Yale study offers critical clues for future norovirus treatments

As the leading cause of viral gastroenteritis worldwide, norovirus is an all too familiar ailment. Its telltale digestive upset — not to mention its reputation for being notoriously contagious — has earned it the nicknames "winter vomiting bug" and "stomach flu."

26 Jun 2026

Engineered CAR T cells successfully target bladder cancer in mice

Researchers at Weill Cornell Medicine, Cedars-Sinai Medical Center, and Roswell Park Comprehensive Cancer Center have developed genetically engineered CAR T cells that specifically target and kill bladder cancer cells.

26 Jun 2026

Smart nanoplatform uses wound acidity to trigger accelerated healing

Infected wounds pose a significant medical challenge, often leading to delayed healing and complications due to bacterial biofilms and excessive inflammation.

26 Jun 2026

Sugar-coated nanoparticles extend survival in aggressive glioblastoma mouse model

Researchers at Oregon State University have potentially found a new way to treat the most aggressive form of brain cancer, glioblastoma, whose two-year survival rate is less than 30%.

23 Jun 2026

Prime and pull vaccine approach prevents genital herpes infection

Genital herpes is a lifelong infection. While available treatments can manage symptoms, they cannot cure the infection or prevent transmission.

22 Jun 2026

Natural molecule erucamide helps slow progressive retinal degeneration

Many conditions that cause vision loss share a common feature: the gradual breakdown of the retina, the light-sensing tissue at the back of the eye.

22 Jun 2026

New mRNA vaccine shrinks neuroblastoma tumors in preclinical study

A new study from RCSI University of Medicine and Health Sciences demonstrates a novel approach in anticancer vaccine development. Results present the first preclinical evidence to show the efficacy of an mRNA vaccine in targeting neuroblastoma, the deadliest childhood cancer.

18 Jun 2026

Targeted vaccination strategies strengthen global biosecurity and biosafety

Biosafety prevents biohazard risks to humans and the environment, biosecurity protects biological assets from misuse, and One Health is an interdisciplinary framework uniting human, animal, and environmental health—all core to global health protection.

17 Jun 2026

Salt-loaded nanoparticles help deliver fragile gene therapies into cells

Researchers at the University of Houston's College of Pharmacy have discovered an unexpected simple strategy to improve the performance of mRNA vaccines and gene therapeutics: adding salt.

16 Jun 2026

Bionic cooling skin accelerates healing and combats wound infections

As the global burden of infected wounds continues to rise-with over 300 million surgeries performed annually and postoperative infections affecting 5–20% of patients-conventional wound dressings face a critical limitation: no single product has successfully integrated protective function, wearing comfort, and efficient antibacterial activity.

15 Jun 2026

Engineered silica nanoparticles destroy prostate tumors in preclinical study

Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while enhancing anti-tumor immunity, according to a preclinical study led by investigators at Weill Cornell Medicine and the Cornell College of Engineering.

15 Jun 2026